Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Land & Improvements (2016 - 2025)

Utah Medical Products has reported Land & Improvements over the past 13 years, most recently at $1.7 million for Q4 2025.

  • Quarterly results put Land & Improvements at $1.7 million for Q4 2025, up 5.8% from a year ago — trailing twelve months through Dec 2025 was $1.7 million (up 5.8% YoY), and the annual figure for FY2025 was $1.7 million, up 5.8%.
  • Land & Improvements for Q4 2025 was $1.7 million at Utah Medical Products, up from $1.6 million in the prior quarter.
  • Over the last five years, Land & Improvements for UTMD hit a ceiling of $1.7 million in Q4 2025 and a floor of $1.6 million in Q4 2022.
  • Median Land & Improvements over the past 5 years was $1.6 million (2023), compared with a mean of $1.6 million.
  • Biggest five-year swings in Land & Improvements: fell 5.74% in 2022 and later grew 5.8% in 2025.
  • Utah Medical Products' Land & Improvements stood at $1.7 million in 2021, then fell by 5.74% to $1.6 million in 2022, then increased by 2.82% to $1.6 million in 2023, then decreased by 2.08% to $1.6 million in 2024, then grew by 5.8% to $1.7 million in 2025.
  • The last three reported values for Land & Improvements were $1.7 million (Q4 2025), $1.6 million (Q4 2024), and $1.6 million (Q4 2023) per Business Quant data.